InDevR, developer of advanced life science products, announced that its ampliPHOX Colorimetric Detection Technology is being beta site-tested in anticipation of an upcoming product launch. The original intellectual property was licensed from the University of Colorado at Boulder.
The beta sites include the Influenza Division of the Centers for Disease Control and Prevention in Atlanta, the Colorado Department of Public Health and Environment Laboratory Services Division in Denver and the USDA/ARS/WRRC, Produce Safety and Microbiology Research Unit in Albany, Calif. Research and development of the ampliPHOX system was sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, through a cooperative agreement.
InDevR's ampliPHOX detection technology is an innovative new colorimetric detection method for low-density microarray applications based on light-initiated signal amplification through polymerization. The inexpensive ampliPHOX Reader both initiates the amplification process and collects an image of the result.
In addition, the ampliVIEW software is capable of automatic image interpretation, providing the user with immediate results. The ampliPHOX technology is a rapid and inexpensive alternative to traditional fluorescence-based microarray detection methodologies and is anticipated to become commercially available in 2010.
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy